CT perfusion in hepatocellular carcinoma: Is it reliable?
Ninety percent of hepatic cancers are hepatocellular carcinomas (HCC) which have an unfavorable prognosis. HCC is a hypervascular tumor supplied mainly by the hepatic artery. It has a higher blood supply than the surrounding hepatic tissue due to neovascularization. Computed tomography with perfusio...
Saved in:
Published in | Egyptian journal of radiology and nuclear medicine Vol. 48; no. 4; pp. 791 - 798 |
---|---|
Main Authors | , |
Format | Journal Article |
Language | English |
Published |
Elsevier B.V
01.12.2017
SpringerOpen |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Ninety percent of hepatic cancers are hepatocellular carcinomas (HCC) which have an unfavorable prognosis. HCC is a hypervascular tumor supplied mainly by the hepatic artery. It has a higher blood supply than the surrounding hepatic tissue due to neovascularization. Computed tomography with perfusion imaging (CTP) is a non invasive tool which quantifies the blood flow parameters of HCC and compares it to the surrounding tissue.
To prove that CTP is a valuable diagnostic tool in diagnosis of HCC and posttherapeutic assessment.
One hundred and twenty-six HCC patients with 150 focal lesions are enrolled this study. Perfusion parameters are quantified and results are compared to those of triphasic CT.
CTP detected 141 lesions with 94% sensitivity and 40% specificity with elevated arterial perfusion (AP) and perfusion index (PI) with low portal flow (PF). It missed 5 lesions because of their hypovascularity and 4 lesions following radiofrequency ablation (RFA) and trans arterial chemo embolization (TACE).
CTP is a safe and specific imaging tool for diagnosis and assessment of therapeutic interventional procedures in HCC. |
---|---|
ISSN: | 0378-603X |
DOI: | 10.1016/j.ejrnm.2017.07.013 |